APA (7th ed.) Citation

Stass, H., & Dalhoff, A. (2005). The Integrated Use of Pharmacokinetic and Pharmacodynamic Models for the Definition of Breakpoints. Infection, 33(S2), 29-35. https://doi.org/10.1007/s15010-005-8205-z

Chicago Style (17th ed.) Citation

Stass, H., and A. Dalhoff. "The Integrated Use of Pharmacokinetic and Pharmacodynamic Models for the Definition of Breakpoints." Infection 33, no. S2 (2005): 29-35. https://doi.org/10.1007/s15010-005-8205-z.

MLA (9th ed.) Citation

Stass, H., and A. Dalhoff. "The Integrated Use of Pharmacokinetic and Pharmacodynamic Models for the Definition of Breakpoints." Infection, vol. 33, no. S2, 2005, pp. 29-35, https://doi.org/10.1007/s15010-005-8205-z.